Archives: Agenda

• Patient identification: how to find patients who are eligible to participate in trials for rare forms of cancer
• Collaborating with patient advocacy groups to facilitate and boost recruitment
• What makes recruiting for a rare cancer trial unique?

• Exploring communication methods that encourage a collaborative culture across a company
• Implementing a strategy that breaks down silos and redefines how teams work together
• How working closely with other teams can foster collaboration when working towards shared goals

There is an urgency to speed up clinical trial processes. To identify and eliminate operational inefficiencies that cause bottlenecks. To ensure concerted efforts from investigators and study teams, sponsors, and other key operational partners combine to conserve resources and time, and, most importantly, accelerate progress in cancer research.

This presentation explores just how to do so with key insights that look at how to attain:

• Data-driven Selection to Choose a Region for Your Trial Expansion
• Risk Response Strategies and a Mitigation Framework
• Clear Communication and a Culture of Accountability Among Partners
• Case Studies on Canada as a Trial Expansion Region

• Review the challenges of long-term patient engagement and why ongoing communication is crucial
• Explore the role of virtual call centers in bridging patients and research teams
• Understand how virtual centers can alleviate burden on clinical sites and streamline patient management
• Highlight the impact on patient retention, data quality, and timely adverse event reporting

• Evaluating regulation and the impact on oncology clinical
• Navigating the evolving regulatory landscape effectively
• Understanding how the geopolitical landscape is affecting oncology trials inside and outside of the US

• Analyzing the latest trends in technology that assist in delivering a better patient experience
• Utilizing technologies that enhance patient experience and efficiency of study
• Understanding how to successfully incorporate new technology to improve patient trial experience

• Evaluating current trends in AI technology
• Understanding how AI can enhance areas of clinical studies
• Identifying where AI can be incorporated and how to implement this effectively in your company